Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Plasma p-tau217 and glucose metabolism correlate in association neocortical areas in Alzheimer's disease

Title: Plasma p-tau217 and glucose metabolism correlate in association neocortical areas in Alzheimer's disease
Authors: Koenig, Lauren N; Huber, Hanna; Chongtham, Anjalika; Di Molfetta, Guglielmo; Andrews, Randolph D; Lukic, Ana; Shafiian, Neeva; Fillit, Howard M; Blennow, Kaj; Ashton, Nicholas J; Zetterberg, Henrik; Matthews, Dawn C; Pereira, Ana C
Source: Brain Communications ; ISSN 2632-1297
Publisher Information: Oxford University Press (OUP)
Publication Year: 2026
Description: While the biomarkers available for Alzheimer's disease are continually expanding, including clinically approved blood tests, not all of the relationships between various biomarkers have been fully elucidated. In this study, we explore how regional brain metabolism, as measured by fludeoxyglucose-18 (FDG)-PET, relates to plasma biomarkers such as p-tau217, Glial fibrillary acidic protein (GFAP), phosphorylated-tau (p-tau)217/beta-amyloid (Aβ) 42, and Aβ42/40 in a cohort of participants with early symptomatic Alzheimer’s disease. P-tau217 showed a consistent pattern of participants with higher p-tau217 levels having increased hypometabolism in Alzheimer’s disease-related regions in association neocortical areas such as the lateral temporal cortex, the precuneus and inferior parietal cortex and atrophy accompanied by greater cognitive impairment. GFAP also related to regional hypometabolism and atrophy in regions known to be affected in Alzheimer’s disease, though with a slightly different regional pattern. We additionally observed that participants with equivalent biomarker levels still exhibited diverse patterns of FDG-PET and atrophy. This suggests that, despite the above correlations, imaging provides additional information. These findings support and extend our knowledge of how plasma p-tau217 relates to other Alzheimer’s disease biomarkers and cerebral metabolism, helping to contextualize both the benefits and limitations of these plasma biomarkers.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1093/braincomms/fcag074
DOI: 10.1093/braincomms/fcag074/67359694/fcag074.pdf
Availability: https://doi.org/10.1093/braincomms/fcag074; https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcag074/67359694/fcag074.pdf
Rights: https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.1FBD05FA
Database: BASE